Loading clinical trials...
Loading clinical trials...
A Multi-Center, Double-Blind, Randomized Study Comparing the Efficacy of Combination Therapy of Eprosartan Respectively Ramipril With Low-Dose Hydrochlorothiazide and Moxonidine on Blood Pressure Levels in Patients With Hypertension and Associated Diabetes Mellitus Type 2
This study is to demonstrate the superiority of combination of eprosartan/HCTZ versus ramipril/HCTZ.
Age
40 - 80 years
Sex
ALL
Healthy Volunteers
No
Site 26
Calgary, Canada
Site 27
Montreal, Canada
Site 30
Québec, Canada
Site 31
Thornhill, Canada
Site 28
Vancouver, Canada
Site 29
Winnipeg, Canada
Site 39
Holbæk, Denmark
Site 38
Roskilde, Denmark
Site 40
Viborg, Denmark
Site 4
Anzin, France
Start Date
October 1, 2004
Last Updated
January 30, 2009
440
Estimated participants
eprosartan/HCTZ
DRUG
Lead Sponsor
Solvay Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07296484